ABBVAbbVie Inc.vs its industry peers
A metric-by-metric comparison of AbbVie Inc. against its industry peers — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
Full peer comparison
Peers: Tickwind curated| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBVThis | $435.3B#2 | 121.4x#5 | — | 7.1x#5 | 8.6%#1 | -1.2%#4 | 24.6%#2 | — | 20.0%#2 | — | 29.8%#3 | — |
| JNJ | $617.8B#1 | 29.7x#3 | 7.6x#4 | 6.6x#4 | 6.0%#2 | 90.6%#2 | 22.9%#3 | 33.0%#3 | 16.8%#3 | 5#2 | 66.1%#1 | 2.0%#3 |
| PFE | $138.3B#4 | 18.5x#2 | 1.5x#1 | 2.2x#1 | -1.6%#5 | -3.2%#5 | 16.3%#5 | 8.6%#4 | 6.7%#5 | — | 0.8%#5 | 7.1%#1 |
| MRK | $305.3B#3 | 34.8x#4 | 6.7x#3 | 4.7x#3 | 1.3%#3 | 6.6%#3 | 34.2%#1 | 39.8%#1 | 21.5%#1 | — | 51.0%#2 | 2.7%#2 |
| BMY | $117.1B#5 | 16.1x#1 | 5.8x#2 | 2.4x#2 | -0.2%#4 | 178.8%#1 | 21.8%#4 | 35.2%#2 | 14.4%#4 | 8#1 | 23.4%#4 | — |
Peer set: Tickwind's hand-curated industry grouping. Values from SEC filings + delayed prices; ranks are sorted positions within this group only — descriptive, not a rating or advice.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice